JNJ vs VRTX
By Alex · Tickerpine
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | VRTX |
|---|---|---|
| Price | $271.95 | $527.67 |
| Market cap | $655.37B | $133.74B |
| P/E ratio | 31.4 | 30.8 |
| ROE | 25.74% | 23.54% |
| Profit margin | 21.48% | 35.00% |
| Revenue growth | 6.60% | 12.50% |
| Dividend yield | 1.97% | — |
| Beta | 0.23 | 0.32 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs VRTX in plain English
- JNJ is the bigger company — about 4.9× the market cap of VRTX.
- VRTX is cheaper on earnings (P/E 30.8 vs 31.4).
- JNJ earns a higher return on equity (26% vs 24%).
- VRTX is growing revenue faster (12% vs 7%).
- JNJ pays a dividend (1.97%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.